| scholarly article | Q13442814 |
| P50 | author | Ian J Amanna | Q73299765 |
| Mark K. Slifka | Q97424936 | ||
| Erika Hammarlund | Q113287674 | ||
| Matthew W. Lewis | Q55873547 | ||
| P2093 | author name string | Lisa I Strelow | |
| Scott G Hansen | |||
| Scott W Wong | |||
| Jon M Hanifin | |||
| Paul Yoshihara | |||
| Shirley V Carter | |||
| P2860 | cites work | A prospective study of serum antibody and protection against smallpox | Q70453198 |
| Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. | Q24533189 | ||
| The looming threat of bioterrorism | Q33536420 | ||
| Cowpox with severe generalized eruption, Finland | Q34560041 | ||
| Human monkeypox: clinical features of 282 patients | Q34684611 | ||
| Human monkeypox: an emerging zoonosis | Q35628219 | ||
| Real-time PCR assay to detect smallpox virus | Q35638821 | ||
| Immunological memory to viral infection | Q35832020 | ||
| A study of inapparent infection in smallpox | Q36540027 | ||
| Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells | Q37093632 | ||
| Serological relatedness of monkeypox, variola, and vaccinia viruses | Q39479899 | ||
| Human cowpox 1969-93: a review based on 54 cases. | Q40654611 | ||
| Analysis of the monkeypox virus genome | Q42679073 | ||
| The detection of monkeypox in humans in the Western Hemisphere. | Q43217764 | ||
| Duration of antiviral immunity after smallpox vaccination | Q43485360 | ||
| Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. | Q43550163 | ||
| Feline orthopoxvirus infection transmitted from cat to human. | Q44578447 | ||
| A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values | Q44701694 | ||
| Smallpox: anything to declare? | Q47438532 | ||
| Human monkeypox: a study of 2,510 contacts of 214 patients | Q53886277 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mpox | Q382370 |
| Orthopoxvirus monkeypox | Q6900886 | ||
| P304 | page(s) | 1005-1011 | |
| P577 | publication date | 2005-08-07 | |
| P1433 | published in | Nature medicine | Q1633234 |
| P1476 | title | Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox | |
| P478 | volume | 11 |
| Q42200927 | A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. |
| Q35201175 | Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques. |
| Q34147526 | Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories |
| Q36869365 | Antibody responses to vaccinia membrane proteins after smallpox vaccination |
| Q34416523 | Antiviral immunity following smallpox virus infection: a case-control study |
| Q37888085 | CD8+ T cell differentiation in the aging immune system: until the last clone standing |
| Q37269295 | Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge |
| Q33967713 | Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model |
| Q50420437 | Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires |
| Q34196228 | Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response |
| Q40494092 | Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections |
| Q38799357 | Defending against smallpox: a focus on vaccines |
| Q30228332 | Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers |
| Q38534549 | Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression |
| Q30228429 | Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment |
| Q37473688 | Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. |
| Q51146797 | Evolution of Synonymous Codon Usage Bias in West African and Central African Strains of Monkeypox Virus |
| Q58789765 | Heterogeneity and longevity of antibody memory to viruses and vaccines |
| Q33896995 | How advances in immunology provide insight into improving vaccine efficacy. |
| Q39245604 | Human CD4 T cell epitopes selective for Vaccinia versus Variola virus |
| Q64361225 | Human Monkeypox: Current State of Knowledge and Implications for the Future |
| Q59349752 | Identifying and Tracking Low-Frequency Virus-Specific TCR Clonotypes Using High-Throughput Sequencing |
| Q34077312 | Immune memory and aging: an infinite or finite resource? |
| Q35828885 | Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. |
| Q39310460 | Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. |
| Q36628965 | LC16m8: an attenuated smallpox vaccine |
| Q42619783 | Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox |
| Q34136736 | Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo |
| Q39023427 | Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection |
| Q64988514 | Molecular Evidence of Human Monkeypox Virus Infection, Sierra Leone. |
| Q101472204 | Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution |
| Q57102607 | Monkeypox outbreak diagnostics and implications for vaccine protective effect |
| Q37287795 | Monkeypox virus and insights into its immunomodulatory proteins |
| Q36936414 | Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation |
| Q36313439 | Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection |
| Q33686180 | Occupational risks during a monkeypox outbreak, Wisconsin, 2003 |
| Q35964833 | Optimization of Peptide-Based ELISA for Serological Diagnostics: A Retrospective Study of Human Monkeypox Infection |
| Q36406894 | Poxviruses: past, present and future. |
| Q34469836 | Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies |
| Q30994031 | Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. |
| Q34517426 | Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice |
| Q36498147 | Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine |
| Q36944950 | Retrospective analysis of monkeypox infection |
| Q45326387 | Retrospective proteomic analysis of serum after Akhmeta virus infection: new suspect case identification and insights into poxvirus humoral immunity |
| Q36727280 | Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects |
| Q37009092 | Serologic evidence for novel poxvirus in endangered red Colobus monkeys, Western Uganda. |
| Q33972574 | Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity |
| Q35800424 | Smallpox subunit vaccine produced in Planta confers protection in mice |
| Q22305942 | Smallpox vaccines for biodefense: need and feasibility |
| Q33800871 | Spectrum of infection and risk factors for human monkeypox, United States, 2003. |
| Q37970180 | Status of human monkeypox: clinical disease, epidemiology and research |
| Q27679281 | Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5 |
| Q33618867 | T cell inactivation by poxviral B22 family proteins increases viral virulence |
| Q36571482 | Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment |
| Q36559797 | Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine |
Search more.